Protein Energy Wasting in a Sample of Egyptian Children on Regular Hemodialysis: Relation to Anorexigenic Hormones

Authors

  • Ragia M. Said Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt
  • Maged A. El Wakeel Department of Child Health, National Research Centre, Cairo, Egypt
  • Ghada M. El-Kassas Department of Child Health, National Research Centre, Cairo, Egypt
  • Hend H. Mostafa Department of Child Health, National Research Centre, Cairo, Egypt
  • Alyaa H. Kamhawy Department of Child Health, National Research Centre, Cairo, Egypt
  • Essam M. Galal Department of Child Health, National Research Centre, Cairo, Egypt
  • Maysa S. Nassar Department of Child Health, National Research Centre, Cairo, Egypt
  • Salwa Refat El-Zayat Department of Medical Physiology, National Research Centre, Cairo, Egypt
  • Nevein N. Fadl Department of Medical Physiology, National Research Centre, Cairo, Egypt

DOI:

https://doi.org/10.3889/oamjms.2020.4981

Keywords:

ESRD, uremic wasting, Hemodialysis, Anthropometric parameters, Unacylated ghrelin, Obestatin

Abstract

BACKGROUND: Increased incidence of pediatric end-stage renal disease (ESRD) with associated serious consequences indicating a major public health problem. Malnutrition and uremic wasting are leading causes of growth impairment and increasing morbidity and mortality of pediatric ESRD patients, predominantly those on regular hemodialysis (HD). Ghrelin and obestatin, which are known appetite regulatory hormones, might have a pivotal role in uremic wasting and growth impairment in hemodialyzed children.

AIM: The aim of the present study was to measure serum unacylated ghrelin (UAG) and obestatin and to investigate their roles in the growth impairment of Egyptian hemodialyzed children.

SUBJECTS AND METHODS: The study included 50 hemodialyzed and 40 healthy children recruited from the Department of Nephrology, Pediatric Hospital, Ain Shams University. Full clinical examination and measurement of anthropometric indices were done. Routine labs were done as well, with an assessment of serum levels of obestatin, UAG, and insulin by enzyme linked immunosorbent assay. Furthermore, we determined fasting serum glucose and lipid profile with the calculation of homeostasis model assessment for insulin resistance (HOMA-IR).

RESULTS: Anthropometric measurements were statistically significantly decreased in the hemodialyzed group than that of the control group (p < 0.05). Weight z-score was the most affected anthropometric parameter (37 patients = 74% with underweight and 13 patients = 26% with normal weight). The hemodialyzed children showed a significant increase of UAG, obestatin, insulin, glucose, HOMA-IR, and TG, while a significant decrease of HDL-cholesterol and albumin (p < 0.01). UAG had a negative correlation with Wt-z score, Ht z-score, fat mass %, albumin, and TG while obestatin was inversely correlated to Wt-z score, BMI z-score, waist circumference, and waist-height ratio (W/H).

CONCLUSION: UAG and obestatin hormones were elevated in a group of Egyptian children on regular HD. These hormones were strongly related to the impairment of renal functions, and anthropometric parameters, dyslipidemia, hypoalbuminemia, and insulin resistance in these pediatric hemodialyzed patients.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Sanyaolu A, Okorie C, Annan R, Turkey H, Akhtar N, Gray F, et al. Epidemiology and management of chronic renal failure: A global public health problem. Biostat Epidemiol Int J 2018;1(1):11-6. https://doi.org/10.30881/beij.00005

El-Ballat MA, El-Sayed MA, Emam HK. Epidemiology of end stage renal disease patients on regular hemodialysis in El-Beheira governorate, Egypt. Egypt J Hosp Med 2019;76(3):3618-25.

Lotfy HM, Sabry SM, Ghobrial EE, Abed SA. The effect of regular hemodialysis on the nutritional status of children with end-stage renal disease. Saudi J Kidney Dis Transpl 2015;26(2):263. https://doi.org/10.4103/1319-2442.152416 PMid:25758873

Foucan L, Merault H, Velayoudom-Cephise FL, Larifla L, Alecu C, Ducros J. Impact of protein energy wasting status on survival among Afro-Caribbean hemodialysis patients: A 3-year prospective study. Springerplus 2015;4(1):452. https://doi. org/10.1186/s40064-015-1257-3 PMid:26322258

Mak RH, Cheung WW, Zhan JY, Shen Q, Foster BJ. Cachexia and protein-energy wasting in children with chronic kidney disease. Pediatr Nephrol 2012;27(2):173-81. https://doi. org/10.1007/s00467-011-1765-5 PMid:21298504

Obi Y, Qader H, Kovesdy CP, Kalantar-Zadeh K. Latest consensus and update on protein energy-wasting in chronic kidney disease. Curr Opin Clin Nutr Metab Care 2015;18(3):254. https://doi.org/10.1097/mco.0000000000000171 PMid:25807354

Rezeq HA, Khdair LN, Hamdan ZI, Sweileh WM. Prevalence of malnutrition in hemodialysis patients: A single-center study in Palestine. Saudi J Kidney Dis Transpl 2018;29(2):332-40. https://doi.org/10.4103/1319-2442.229264 PMid:29657201

El Wakeel MA, El-Kassas GM, Hashem SA, Abouelnaga MW, Elzaree FA, Hassan M, et al. Potential role of oxidative stress in childhood obesity and its relation to inflammation. Biosci Res 2018;15(4):3791-9.

Wang Z, Oliveira EA, Mak RH. Unacylated ghrelin and obestatin in pediatric CKD: Are they important in protein energy wasting? Pediatr Nephrol 2018;33(5):741-3. https://doi.org/10.1007/ s00467-018-3891-9 PMid:29453692

Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar- Zadeh K, Kaysen G, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: A consensus statement from the international society of renal nutrition and metabolism (ISRNM). J Ren Nutr 2013;23(2):77-90. https://doi. org/10.1053/j.jrn.2013.01.001 PMid:23428357

Zoccali C, Mallamaci F. Obestatin, a ghrelin-cognate protein, and clinical outcomes in hemodialysis patients. Am J Nephrol 2018;47(4):251-3. https://doi.org/10.1159/000488287 PMid:29694953

Bek SG, Batman A, Eraldemir C, Eren N, Bakirdogen S, Dervişoğlu E. Serum ghrelin levels: Is there any association with malnutrition and depres-sion in peritoneal dialysis patients? Hippokratia 2018;22(1):43-8. PMid:31213757

Gil-Campos M, Aguilera CM, Canete R, Gil A. Ghrelin: A hormone regulating food intake and energy homeostasis. Br J Nutr 2006;96(2):201-26. https://doi.org/10.1079/bjn20061787 PMid:16923214

Pérez-Fontán M, Cordido F, Rodríguez-Carmona A, Peteiro J, García-Naveiro R, García-Buela J. Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis. Nephrol Dial Transpl 2004;19(8):2095-100. https://doi. org/10.1093/ndt/gfh313 PMid:15187192

Iglesias P, Díez JJ, Fernández-Reyes MJ, Codoceo R, Alvarez-Fidalgo P, Bajo MA, et al. Serum ghrelin concentrations in patients with chronic renal failure undergoing dialysis. Clin Endocrinol 2006;64(1):68-73. https://doi. org/10.1111/j.1365-2265.2005.02418.x PMid:16402931

Sekar M, Elumalai R, Basappa MK, Lakkakula BV, Periasamy S. Effect of chronic kidney disease on circulating ghrelin concentrations. Ann RSCB 2015;19(2):41-6.

Abdelhamid ER, Kamhawy AH, Ahmed HH, Shady MM, Fathy A, Fahmy RF. Association of cord blood des-acyl ghrelin with Apgar score and anthropometric measures in relation to its maternal one. Biomed Pharmacol J 2019;12(3):1147-54. https:// doi.org/10.13005/bpj/1743

Eftekhari MH, Ranjbar-Zahedani M, Basiratnia M, Rezaianzadeh A, Faghih S. Comparison of appetite-regulating hormones and body composition in pediatric patients in predialysis stage of chronic kidney disease and healthy control group. Iran J Med Sci 2015;40(1):27-33. PMid:25649956

Monzani A, Perrone M, Prodam F, Moia S, Genoni G, Testa S, et al. Unacylated ghrelin and obestatin: Promising biomarkers of protein energy wasting in children with chronic kidney disease. Pediatr Nephrol 2018;33(4):661-72. https://doi.org/10.1007/ s00467-017-3840-z PMid:29150712

Müller TD, Nogueiras R, Andermann ML, Andrews ZB, Anker SD, Argente J, et al. Ghrelin. Mol Metab 2015;4(6):437-60. PMid:26042199

Katkov A, Sinuani I, Azar A, Shapiro G, Efrati S, Beberashvili I. Age modifies the association between serum obestatin, appetite and nutritional status in maintenance hemodialysis patients. Eur J Clin Nutr 2018;72(7):1007-18. https://doi.org/10.1038/ s41430-018-0087-0 PMid:29362457

World Health Organization. WHO AnthroPlus for Personal Computers Manual: Software for Assessing Growth of the World’s Children and Adolescents. Geneva: World Health Organization; 2009. Available from: http://www.who.int/ growthref/tools/en. [Last accessed on 2019 October 10].

Siri WE. Body composition from fluid spaces and density: Analysis of methods. Nutrition 1961 1993;9(5):223-44. PMid:8286893

Narasimha Rai K, Kumari NS, Damodara Gowda KM, Swathi KR. The evaluation of micronutrients and oxidative stress and their relationship with the lipid profile in healthy adults. J Clin Diagn Res 2013;7(7):1314-8. https://doi.org/10.7860/ jcdr/2013/6127.3124 PMid:23998054

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18(6):499-502. https://doi.org/10.1093/clinchem/18.6.499 PMid:4337382

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28(7):412-9. https:// doi.org/10.1007/bf00280883 PMid:3899825

Bonthuis M, Van Stralen KJ, Verrina E, Groothoff JW, Melgar AA, Edefonti A, et al. Underweight, overweight and obesity in paediatric dialysis and renal transplant patients. Nephrol Dial Transplant 2013;28(Suppl 4):iv195-204. https://doi.org/10.1093/ ndt/gft259 PMid:23975752

Zaki ME, Hassan MM, Bazaraa HM, Ahmed HF. Nutritional status in children with chronic renal failure on hemodialysis. Maced J Med Sci 2012;5(3):296-301.

Rodig NM, McDermott KC, Schneider MF, Hotchkiss HM, Yadin O, Seikaly MG, et al. Growth in children with chronic kidney disease: A report from the chronic kidney disease in children study. Pediatr Nephrol 2014;29(10):1987-95. https:// doi.org/10.1007/s00467-014-2812-9 PMid:24728472

Rees L. Growth hormone therapy in children with CKD after more than two decades of practice. Pediatr Nephrol 2016;31(9):1421- 35. https://doi.org/10.1007/s00467-015-3179-2 PMid:26369925

Arbeiter AK, Büscher R, Petersenn S, Hauffa BP, Mann K, Hoyer PF. Ghrelin and other appetite-regulating hormones in paediatric patients with chronic renal failure during dialysis and following kidney transplantation. Nephrol Dial Transplant 2009;24(2):643-6. https://doi.org/10.1093/ndt/gfn529 PMid:18809976

Naufel MF, Bordon M, de Aquino TM, Ribeiro EB, de Abreu Carvalhaes JT. Plasma levels of acylated and total ghrelin in pediatric patients with chronic kidney disease. Pediatr Nephrol 2010;25(12):2477-82. https://doi.org/10.1007/ s00467-010-1628-5 PMid:20734087

Büscher AK, Büscher R, Hauffa BP, Hoyer PF. Alterations in appetite-regulating hormones influence protein energy wasting in pediatric patients with chronic kidney disease. Pediatr Nephrol 2010;25(11):2295-301. https://doi.org/10.1007/ s00467-010-1588-9 PMid:20607302

Canpolat N, Sever L, Agbas A, Tasdemir M, Oruc C, Ekmekci OB, et al. Leptin and ghrelin in chronic kidney disease: Their associations with protein-energy wasting. Pediatr Nephrol 2018;33(11):2113-22. https://doi.org/10.1007/ s00467-018-4002-7 PMid:29980850

El-Khashab SO, Behiry ME. Adiponectin and ghrelin: Nutritional regulatory role in chronic kidney disease patients. Egypt J Intern Med 2019;31(1):99. https://doi.org/10.4103/ejim.ejim_78_18

Yoshimoto A, Mori K, Sugawara A, Mukoyama M, Yahata K, Suganami T, et al. Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 2002;13(11):2748-52. https://doi.org/10.1097/01. asn.0000032420.12455.74 PMid:12397045

Gupta RK, Kuppusamy T, Patrie JT, Gaylinn B, Liu J, Thorner MO, et al. Association of plasma des-acyl ghrelin levels with CKD. Clin J Am Soc Nephrol 2013;8(7):1098-105. https:// doi.org/10.2215/cjn.09170912 PMid:23744005

Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, Jin Z, et al. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci 200829;105(17):6320- 5. https://doi.org/10.1073/pnas.0800708105 PMid:18443287

De Vriese C, Hacquebard M, Gregoire F, Carpentier Y, Delporte C. Ghrelin interacts with human plasma lipoproteins. Endocrinology 2007;148(5):2355-62. https://doi.org/10.1210/ en.2006-1281 PMid:17289852

Mafra D, Guebre-Egziabher F, Cleaud C, Arkouche W, Mialon A, Drai J, et al. Obestatin and ghrelin interplay in hemodialysis patients. Nutrition 2010;26(11-12):1100-4. https:// doi.org/10.1016/j.nut.2009.09.003 PMid:20018486

Beberashvili I, Ptashkin E, Azar A, Hamad RA, Koren S, Stav K, et al. Obestatin levels in response to a meal and association with subsequent appetite sensations in maintenance hemodialysis patients. Clin Nutr 2020;2020:30063. https://doi.org/10.1016/j. clnu.2020.02.015

Depoortere I, Thijs T, Moechars D, De Smet B, Ver Donck L, Peeters TL. Effect of peripheral obestatin on food intake and gastric emptying in ghrelin-knockout mice. Br J Pharmacol 2008;153(7):1550-7. https://doi.org/10.1038/sj.bjp.0707683 PMid:18204478

Rees L. Protein energy wasting; what is it and what can we do to prevent it? Pediatr Nephrol 2019;1-8. https://doi.org/10.1007/ s00467-019-04424-2 PMid:31834488

Asakawa A, Inui A, Fujimiya M, Sakamaki R, Shinfuku N, Ueta Y, et al. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 2005;54(1):18-24. https://doi. org/10.1136/gut.2004.038737 PMid:15591499

Muscaritoli M, Molfino A, Chiappini MG, Laviano A, Ammann T, Spinsanti P, et al. Anorexia in hemodialysis patients: The possible role of des-acyl ghrelin. Am J Nephrol 2007;27(4):360- 5. https://doi.org/10.1159/000103798 PMid:17556836

Akamizu T, Kangawa K. Therapeutic applications of ghrelin to cachexia utilizing its appetite-stimulating effect. Peptides 2011;32(11):2295-300. https://doi.org/10.1016/j. peptides.2011.05.018 PMid:21635929

Ayala ER, Pecoits-Filho R, Heimbürger O, Lindholm B, Nordfors L, Stenvinkel P. Associations between plasma ghrelin levels and body composition in end-stage renal disease: A longitudinal study. Nephrol Dial Transplant 2004;19(2):421-6. https://doi.org/10.1093/ndt/gfg559 PMid:14736968

Prodam F, Monzani A, Ricotti R, Marolda A, Bellone S, Aimaretti G, et al. Systematic review of ghrelin response to food intake in pediatric age, from neonates to adolescents. J Clin Endocrinol Metab 2014;99(5):1556-68. https://doi.org/10.1210/ jc.2013-4010 PMid:24601727

Johansen KL, Lee C. Body composition in chronic kidney disease. Curr Opin Nephrol Hypertens 2015;24(3):268. PMid:25887900

Alves FC, Sun J, Qureshi AR, Dai L, Snaedal S, Barany P, et al. The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease. PLoS One 2018;13(1):e0190410. https://doi. org/10.1371/journal.pone.0190410 PMid:29298330

Stenvinkel P, Barany P, Chung SH, Lindholm B, Heimbürger O. A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients. Nephrol Dial Transpl 2002;17(7):1266-74. https://doi.org/10.1093/ ndt/17.7.1266 PMid:12105251

Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: Pathogenesis and clinical significance. J Parenter Enteral Nutr 2019;43:181-93. https://doi.org/10.1002/jpen.1451 PMid:30288759

Qunibi WY. Dyslipidemia in dialysis patients. In: Seminars in Dialysis. Vol. 28. New York: Wiley Online Library; 2015. p. 345- 53. https://doi.org/10.1111/sdi.12375

Gluba-Brzozka A, Franczyk B, Rysz J. Cholesterol disturbances and the role of proper nutrition in CKD patients. Nutrients 2019;11(11):2820. https://doi.org/10.3390/nu11112820 PMid:31752189

Ragab M, Ragab A. Assessment of lipid profile in Egyptian children with chronic kidney diseases on conservative therapy and those under regular hemodialysis. J Med Sci 2007;7(5):825-9.

Tannock L. Dyslipidemia in Chronic Kidney Disease. In: Endotext. San Francisco, CA: MDText Com, Inc.; 2018.

Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Kratzsch J, Blüher M, et al. Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis. Metabolism 2008;57(10):1414-21. https://doi.org/10.1016/j.metabol.2008.05.011 PMid:18803947

Shouman MG, Ibrahim HY, Bazaraa H, Salama EE, El Malt HA. Adipocytokines in pediatric hemodialysis patients. Res J Med Med Sci 2009;4:533-7.

Elsayed NM, Hamed ST, El-Khatib MM, El-Shehaby AM. The relation between dual energy x-ray absorptiometry measurement of body fat composition and plasma ghrelin in patients with end-stage renal disease. Saudi Med J 2009;30(1):109-15. PMid:19139783

Nagaraj S, Peddha MS, Manjappara UV. Fragments of obestatin as modulators of feed intake, circulating lipids, and stored fat. Biochem Biophys Res Commun 2008;366(3):731-7. https://doi. org/10.1016/j.bbrc.2007.12.036

Agnew A, Calderwood D, Chevallier OP, Greer B, Grieve DJ, Green BD. Chronic treatment with a stable obestatin analog significantly alters plasma triglyceride levels but fails to influence food intake; fluid intake; body weight; or body composition in rats. Peptides 2011;32(4):755-62. https://doi.org/10.1016/j. peptides.2010.12.005 PMid:21167891

Abulfadle KA, Saied AA. Role of obestatin in improvement of obesity-induced metabolic and kidney function changes in exercised rats. Am J Biomed Sci 2019;11(2):74-89. https://doi. org/10.5099/aj190200074

Hung AM, Ikizler TA. Factors determining insulin resistance in chronic hemodialysis patients. In: Hemodialysis. Vol. 171. Basel, Switzerland: Karger Publishers; 2011. p. 127-34. https:// doi.org/10.1159/000327177

Barazzoni R, Zanetti M, Ferreira C, Vinci P, Pirulli A, Mucci M, et al. Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. J Clin Endocrinol Metab 2007;92(10):3935-40. https://doi.org/10.1210/ jc.2006-2527 PMid:17652221

Barazzoni R, Cappellari GG, Semolic AN, Ius M, Mamolo L, Dore F, et al. Plasma total and unacylated ghrelin predict 5-year changes in insulin resistance. Clin Nutr 2016;35(5):1168-73. https://doi.org/10.1016/j.clnu.2015.10.002 PMid:26508327

Cappellari GG, Zanetti M, Semolic A, Vinci P, Ruozi G, Falcione A, et al. Unacylated ghrelin reduces skeletal muscle reactive oxygen species generation and inflammation and prevents high-fat diet–induced hyperglycemia and whole-body insulin resistance in rodents. Diabetes 2016;65(4):874-86. https://doi.org/10.2337/db15-1019 PMid:26822085

Downloads

Published

2020-08-25

How to Cite

1.
Said RM, El Wakeel MA, El-Kassas GM, Mostafa HH, Kamhawy AH, Galal EM, Nassar MS, El-Zayat SR, Fadl NN. Protein Energy Wasting in a Sample of Egyptian Children on Regular Hemodialysis: Relation to Anorexigenic Hormones. Open Access Maced J Med Sci [Internet]. 2020 Aug. 25 [cited 2024 Nov. 23];8(B):658-65. Available from: https://oamjms.eu/index.php/mjms/article/view/4981